window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : March 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

RLYB116

  • Biotech,Clinical Development,Clinical Trials,Hematology,Immunology,Pharmaceuticals and therapeutics

    Affibody licensee Rallybio reports Phase 1 data showing sustained complement inhibition with RLYB116

    Affibody has reported positive Phase 1 data from its licensee [...]

    February 19, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SPT Labtech and Illumina to develop automated platform for decentralised oncology genomics
    Categories: Diagnostics, Oncology, Partnerships & Funding
  • Young adults in US, UK and Australia hit hardest by global mental health decline
    Categories: Clinical studies, Digital Health, Global health, Mental health, Neurosciences
  • Study confirms Nerivio REN wearable safe with continuous glucose monitoring devices
    Categories: Clinical studies, Digital Health, Drug Delivery & Formulation, Neurosciences
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top